DE602005022481D1 - Zusammensetzungen und deren verwendung für besseren gefässzugang - Google Patents

Zusammensetzungen und deren verwendung für besseren gefässzugang

Info

Publication number
DE602005022481D1
DE602005022481D1 DE602005022481T DE602005022481T DE602005022481D1 DE 602005022481 D1 DE602005022481 D1 DE 602005022481D1 DE 602005022481 T DE602005022481 T DE 602005022481T DE 602005022481 T DE602005022481 T DE 602005022481T DE 602005022481 D1 DE602005022481 D1 DE 602005022481D1
Authority
DE
Germany
Prior art keywords
implantable material
cells
present
functional
arteriovenous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005022481T
Other languages
English (en)
Inventor
Helen Marie Nugent
Elazer Edelman
Anupam Dalal
Steve Bollinger
Scott Epperly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pervasis Therapeutics Inc
Original Assignee
Pervasis Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pervasis Therapeutics Inc filed Critical Pervasis Therapeutics Inc
Priority claimed from PCT/US2005/043967 external-priority patent/WO2006062909A2/en
Publication of DE602005022481D1 publication Critical patent/DE602005022481D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3808—Endothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005—The prosthesis being constructed from a particular material
    • A61F2310/00365—Proteins; Polypeptides; Degradation products thereof
DE602005022481T 2004-12-08 2005-12-06 Zusammensetzungen und deren verwendung für besseren gefässzugang Active DE602005022481D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US63415504P 2004-12-08 2004-12-08
US66385905P 2005-03-21 2005-03-21
US68205405P 2005-05-18 2005-05-18
PCT/US2005/043967 WO2006062909A2 (en) 2004-12-08 2005-12-06 Methods and compositions for enhancing vascular access

Publications (1)

Publication Number Publication Date
DE602005022481D1 true DE602005022481D1 (de) 2010-09-02

Family

ID=36578486

Family Applications (2)

Application Number Title Priority Date Filing Date
DE602005018103T Active DE602005018103D1 (de) 2004-12-08 2005-12-06 Materialien und verfahren zur minimal invasiven abgabe einer zellhaltigen fliessfähigen zusammensetzung
DE602005022481T Active DE602005022481D1 (de) 2004-12-08 2005-12-06 Zusammensetzungen und deren verwendung für besseren gefässzugang

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE602005018103T Active DE602005018103D1 (de) 2004-12-08 2005-12-06 Materialien und verfahren zur minimal invasiven abgabe einer zellhaltigen fliessfähigen zusammensetzung

Country Status (12)

Country Link
US (8) US20080125858A1 (de)
EP (5) EP1824417A2 (de)
JP (8) JP2008522738A (de)
CN (4) CN101940801B (de)
AT (2) ATE450276T1 (de)
AU (4) AU2005314312B2 (de)
CA (4) CA2589871A1 (de)
DE (2) DE602005018103D1 (de)
ES (2) ES2490610T3 (de)
HK (2) HK1112429A1 (de)
IL (5) IL183784A (de)
WO (1) WO2006062962A2 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9969980B2 (en) * 2001-09-21 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
US9969977B2 (en) * 2002-09-20 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
DE602006014814D1 (de) 2005-04-21 2010-07-22 Massachusetts Inst Technology Materialien und verfahren zur änderung einer immunreaktion auf exogene und endogene immunogene, einschliesslich genidentischer und nicht-genidentischer zellen, gewebe oder organe
EP2361591A3 (de) 2005-06-21 2011-12-21 Pervasis Therapeutics, Inc. Verfahren und Zusammensetzungen zur Verbesserung des vaskulären Zugangs
CA2654086C (en) 2006-06-02 2016-05-24 St. Michael's Hospital Ultrasonic evaluation of venous structures
WO2008057590A2 (en) * 2006-11-07 2008-05-15 Pervasis Therapeutics, Inc. Methods and compositions for modulating tissue modeling
JP5372764B2 (ja) * 2006-11-07 2013-12-18 シャイア リジェネラティブ メディシン， インコーポレイテッド 血管形成関連疾患の治療および管理のための材料および方法
US20100239671A1 (en) * 2007-11-06 2010-09-23 Edelman Elazer R Tissue-Engineered Endothelial and Epithelial Implants Differentially and Synergistically Regulate Tissue Repair
WO2009149474A1 (en) 2008-06-06 2009-12-10 Vital Access Corporation Tissue management methods, apparatus, and systems
US9179901B2 (en) 2009-01-29 2015-11-10 Vital Access Corporation Vascular access ports and related methods
US11197952B2 (en) 2009-01-29 2021-12-14 Advent Access Pte. Ltd. Vascular access ports and related methods
CA2751185C (en) 2009-01-29 2018-07-03 Vital Access Corporation Vascular access ports and related methods
US20110319976A1 (en) * 2010-01-27 2011-12-29 Sriram Iyer Device and method for preventing stenosis at an anastomosis site
US8551130B2 (en) 2010-02-18 2013-10-08 Cardiovascular Systems, Inc. Therapeutic agent delivery system, device and method for localized application of therapeutic substances to a biological conduit
US9050414B2 (en) 2010-02-19 2015-06-09 Cardiovascular Systems, Inc. Systems and methods for mixing therapeutic agents before and/or during administration
US20110277778A1 (en) * 2010-05-14 2011-11-17 Tyco Healthcare Group Lp System and Method for Diverticulitis Treatment
CN103124492A (zh) * 2010-05-28 2013-05-29 加内特生物治疗学股份有限公司 使用具有来源于体外培养和扩增的自我更新集落形成细胞的组分的有生命的和无生命的生物反应装置的组合物和方法
ES2744949T3 (es) 2011-08-01 2020-02-26 Laminate Medical Tech Ltd Dispositivos de conformación de vasos
US9433722B2 (en) * 2011-08-09 2016-09-06 Abbott Cardiovascular Systems Inc. Vascular shield and delivery system
CN104185485B (zh) * 2011-08-17 2017-07-04 弗洛福沃德医药股份有限公司 增加静脉和动脉的总直径的系统和方法
WO2014017986A1 (en) * 2012-07-26 2014-01-30 Agency For Science, Technology And Research Vascular access device and guiding portion
CN104837514B (zh) 2012-08-01 2017-05-17 拉米内特医疗技术有限公司 用于使动静脉瘘成形的装置
US20150370707A1 (en) * 2014-06-24 2015-12-24 Qualcomm Incorporated Disunited shared-information and private-information caches
US20160029996A1 (en) * 2014-08-01 2016-02-04 Eric Johnson Device and method for using ivus data to characterize and evaluate a vascular graft condition
CN108271770B (zh) * 2017-01-06 2021-06-22 中国科学院化学研究所 微米颗粒在低温冻存中的应用
US11147582B2 (en) 2018-06-14 2021-10-19 Cardio Flow, Inc. Atherectomy devices and methods
US11925640B2 (en) * 2018-06-22 2024-03-12 Mayo Foundation For Medical Education And Research Methods and materials for improving arteriovenous fistula maturation and maintaining arteriovenous fistula functionality
JP2022523129A (ja) * 2019-01-31 2022-04-21 北京華龕生物科技有限公司 幹細胞の大規模調製のための三次元培養方法
IT202000013321A1 (it) 2020-06-05 2021-12-05 Gianni Pecorari Dispositivo di accesso vascolare per emodialisi permanentemente impiantabile in un paziente, dispositivo di cicatrizzazione di accesso vascolare e confezione sterile contenente un dispositivo monouso di prelievo e/o di immissione di sangue utilizzabile in emodialisi
IT201900009318A1 (it) * 2019-06-18 2020-12-18 Gianni Pecorari Dispositivo di accesso vascolare per emodialisi permanentemente impiantabile in un paziente avente una fistola arterovenosa ed una confezione sterile contenente un dispositivo monouso di prelievo e/o d’immissione di sangue detta fistola arterovenosa
WO2020254976A1 (en) * 2019-06-18 2020-12-24 Gianni Pecorari Implantable vascular access device
WO2021161884A1 (ja) * 2020-02-14 2021-08-19 明郎 萩原 血管吻合部の保護カバー
CN115279428A (zh) * 2020-03-03 2022-11-01 萩原明郎 静脉套
WO2023037859A1 (ja) * 2021-09-08 2023-03-16 明郎 萩原 血管カバー
WO2023037861A1 (ja) * 2021-09-08 2023-03-16 明郎 萩原 血管カバー
US11931501B2 (en) 2022-07-07 2024-03-19 Evan T. Neville Dialysis sheath for use in accessing a dialysis arteriovenous graft or fistula and methods of use

Family Cites Families (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4418691A (en) * 1981-10-26 1983-12-06 Massachusetts Institute Of Technology Method of promoting the regeneration of tissue at a wound
US4787900A (en) * 1982-04-19 1988-11-29 Massachusetts Institute Of Technology Process for forming multilayer bioreplaceable blood vessel prosthesis
US4820626A (en) * 1985-06-06 1989-04-11 Thomas Jefferson University Method of treating a synthetic or naturally occuring surface with microvascular endothelial cells, and the treated surface itself
IL78950A (en) * 1985-06-06 1991-12-15 Univ Jefferson Coating for prosthetic devices
US4732155A (en) * 1985-08-27 1988-03-22 The Children's Medical Center Corporation Implantable chemoattractant system
US4675002A (en) * 1985-12-02 1987-06-23 Viles Joseph M Liver assist device employing transformed cell lines
US5863531A (en) * 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US5567612A (en) * 1986-11-20 1996-10-22 Massachusetts Institute Of Technology Genitourinary cell-matrix structure for implantation into a human and a method of making
CA1340581C (en) * 1986-11-20 1999-06-08 Joseph P. Vacanti Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
US5759830A (en) * 1986-11-20 1998-06-02 Massachusetts Institute Of Technology Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo
US5736372A (en) * 1986-11-20 1998-04-07 Massachusetts Institute Of Technology Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
US6309635B1 (en) * 1986-11-20 2001-10-30 Children's Medical Center Corp. Seeding parenchymal cells into compression resistant porous scaffold after vascularizing in vivo
US5202120A (en) * 1987-09-11 1993-04-13 Case Western Reserve University Methods of reducing glial scar formation and promoting axon and blood vessel growth and/or regeneration through the use of activated immature astrocytes
US5575815A (en) * 1988-08-24 1996-11-19 Endoluminal Therapeutics, Inc. Local polymeric gel therapy
US5843156A (en) * 1988-08-24 1998-12-01 Endoluminal Therapeutics, Inc. Local polymeric gel cellular therapy
CH676195A5 (de) * 1988-10-07 1990-12-28 Sulzer Ag
US5527532A (en) * 1989-11-13 1996-06-18 President And Fellows Of Harvard College Extraluminal regulation of the growth and repair of tubular structures in vivo
AU6747790A (en) * 1989-11-13 1991-06-13 President And Fellows Of Harvard College Extraluminal regulation of the growth and repair of tubular structures in vivo
US5540928A (en) * 1991-02-27 1996-07-30 President And Fellows Of Harvard College Extraluminal regulation of the growth and repair of tubular structures in vivo
US5246451A (en) * 1991-04-30 1993-09-21 Medtronic, Inc. Vascular prosthesis and method
CA2071137A1 (en) * 1991-07-10 1993-01-11 Clarence C. Lee Composition and method for revitalizing scar tissue
US5811447A (en) * 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5957972A (en) * 1992-09-29 1999-09-28 Arizona Board Of Regents On Behalf Of The University Of Arizona Implants possessing a surface of endothelial cells genetically-modified to inhibit intimal thickening
US5399665A (en) * 1992-11-05 1995-03-21 Massachusetts Institute Of Technology Biodegradable polymers for cell transplantation
US6491938B2 (en) * 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en) * 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5575686A (en) * 1993-04-14 1996-11-19 Burndy Corporation Stacked printed circuit boards connected in series
US5709854A (en) * 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5645829A (en) * 1993-06-18 1997-07-08 Beth Israel Hospital Association Mesothelial cell gene therapy
US6176874B1 (en) * 1993-10-18 2001-01-23 Masschusetts Institute Of Technology Vascularized tissue regeneration matrices formed by solid free form fabrication techniques
US5834029A (en) * 1994-07-20 1998-11-10 Cytotherapeutics, Inc. Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment
US6911216B1 (en) * 1994-10-12 2005-06-28 Genzyme Corporation Targeted delivery via biodegradable polymers
ATE198979T1 (de) * 1994-10-12 2001-02-15 Focal Inc Zielgerichte verabreichung mittels biologisch abbaubarer polymere
US5914268A (en) * 1994-11-21 1999-06-22 National Jewish Center For Immunology & Respiratory Medicine Embryonic cell populations and methods to isolate such populations
US6281015B1 (en) * 1994-12-16 2001-08-28 Children's Medical Center Corp. Localized delivery of factors enhancing survival of transplanted cells
US5716404A (en) * 1994-12-16 1998-02-10 Massachusetts Institute Of Technology Breast tissue engineering
US5591226A (en) * 1995-01-23 1997-01-07 Schneider (Usa) Inc. Percutaneous stent-graft and method for delivery thereof
US5855610A (en) * 1995-05-19 1999-01-05 Children's Medical Center Corporation Engineering of strong, pliable tissues
US5766584A (en) * 1995-06-02 1998-06-16 Massachusetts Institute Of Technology Inhibition of vascular smooth muscle cell proliferation with implanted matrix containing vascular endothelial cells
US6615071B1 (en) * 1995-09-20 2003-09-02 Board Of Regents, The University Of Texas System Method and apparatus for detecting vulnerable atherosclerotic plaque
US6480743B1 (en) * 2000-04-05 2002-11-12 Neuropace, Inc. System and method for adaptive brain stimulation
US6102884A (en) * 1997-02-07 2000-08-15 Squitieri; Rafael Squitieri hemodialysis and vascular access systems
US6886568B2 (en) * 1998-04-08 2005-05-03 The Johns Hopkins University Method for fabricating cell-containing implants
AU766693B2 (en) * 1998-11-24 2003-10-23 Emory University Transgenic circulating endothelial cells
US6328762B1 (en) * 1999-04-27 2001-12-11 Sulzer Biologics, Inc. Prosthetic grafts
US6387116B1 (en) * 1999-06-30 2002-05-14 Pharmasonics, Inc. Methods and kits for the inhibition of hyperplasia in vascular fistulas and grafts
US6584590B1 (en) * 1999-08-13 2003-06-24 Lucent Technologies Inc. JTAG port-sharing device
US6555374B1 (en) * 1999-08-19 2003-04-29 Artecel Sciences, Inc. Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof
AU777833B2 (en) * 1999-10-05 2004-11-04 Transkaryotic Therapies, Inc. Hybrid matrices and hybrid matrix mixtures
US6461631B1 (en) * 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition
US20010047843A1 (en) * 1999-12-22 2001-12-06 Reinig Maureen Louise Handicraft process for creating cards
AU2001243248A1 (en) * 2000-02-23 2001-09-03 Smith Kline Beecham Corporation Method for the prevention or reduction of vascular access dysfunction
DE60130544T2 (de) * 2000-03-13 2008-06-26 Biocure, Inc. Embolische zusammensetzungen
CA2400319C (en) * 2000-03-15 2008-09-16 Orbus Medical Technologies Inc. Coating that promotes endothelial cell adherence
US6506398B1 (en) * 2000-04-28 2003-01-14 Hosheng Tu Device for treating diabetes and methods thereof
WO2002007749A2 (en) * 2000-07-21 2002-01-31 Board Of Regents, The University Of Texas System Device providing regulated growth factor delivery for the regeneration of peripheral nerves
AU2001296558A1 (en) * 2000-10-03 2002-04-15 Oncopharmaceutical, Inc. Inhibitors of angiogenesis and tumor growth for local and systemic administration
US6622031B1 (en) * 2000-10-04 2003-09-16 3Com Corporation Antenna flip-up on removal of stylus for handheld device
JP3580239B2 (ja) * 2000-10-19 2004-10-20 日本電気株式会社 言語選択同報システム及び言語選択同報方法
US6565601B2 (en) * 2000-11-15 2003-05-20 Micro Therapeutics, Inc. Methods for vascular reconstruction of diseased arteries
JP4004952B2 (ja) * 2000-11-28 2007-11-07 ザ ユニヴァーシティ オヴ シカゴ 心血管疾患治療のための遺伝的に操作されたヘルペスウイルス
NZ527046A (en) * 2001-01-16 2005-06-24 Vascular Therapies Llc A flexible cylindrical matrix material, preferably collagen with an antiproliferative agent preferably rapamycin dispersed throughout for implantation to be in contact with a vascular structure
US6723131B2 (en) * 2001-02-28 2004-04-20 The Cleveland Clinic Foundation Composite bone marrow graft material with method and kit
US6969373B2 (en) * 2001-04-13 2005-11-29 Tricardia, Llc Syringe system
US20030036720A1 (en) * 2001-08-17 2003-02-20 Spencer Dudley W.C. Hemodialysis assembly and method
US6808518B2 (en) * 2001-09-28 2004-10-26 Ethicon, Inc. Methods and devices for treating diseased blood vessels
US20040047843A1 (en) * 2002-02-12 2004-03-11 Uab Research Foundation Method for spinal cord reconnection
US20050008629A1 (en) * 2002-05-08 2005-01-13 Interpore Orthopaedics, A Delaware Corporation Encapsulated AGF cells
CA2490811A1 (en) * 2002-06-28 2004-01-08 Novartis Ag Use of organic compounds
US20040156878A1 (en) * 2003-02-11 2004-08-12 Alireza Rezania Implantable medical device seeded with mammalian cells and methods of treatment
US20040215220A1 (en) * 2003-04-24 2004-10-28 Dolan Mark J. Anastomotic stent, apparatus and methods of use thereof
EP1682196A2 (de) * 2003-11-10 2006-07-26 Angiotech International Ag Medizinische implantate und anti-narben-mittel
US20050106554A1 (en) * 2003-11-19 2005-05-19 Palecek Sean P. Cryopreservation of pluripotent stem cells
US20050208095A1 (en) * 2003-11-20 2005-09-22 Angiotech International Ag Polymer compositions and methods for their use
US20060004316A1 (en) * 2004-07-02 2006-01-05 Difiore Attilio E Reduction of recirculation in catheters
US7976517B2 (en) * 2004-09-30 2011-07-12 Codman & Shurtleff, Inc. Fluid management flow implants of improved occlusion resistance
US7882863B2 (en) * 2005-10-19 2011-02-08 Cd Solutions, Llc Apparatus and method for mixing and transferring medications
PL1951344T3 (pl) * 2005-11-07 2015-02-27 Borla Ind Odpowietrzana bezpieczna podczas obsługi przystawka pośrednicząca do fiolki

Also Published As

Publication number Publication date
IL212764A0 (en) 2011-07-31
HK1112428A1 (en) 2008-09-05
CA2589588A1 (en) 2006-06-15
JP2012176260A (ja) 2012-09-13
EP2184077A1 (de) 2010-05-12
JP2013056202A (ja) 2013-03-28
CA2589871A1 (en) 2006-06-15
EP1824417A2 (de) 2007-08-29
IL209574A0 (en) 2011-01-31
IL183784A0 (en) 2008-04-13
CN102772824A (zh) 2012-11-14
AU2010249280B2 (en) 2012-10-18
US20080125858A1 (en) 2008-05-29
AU2010249280A1 (en) 2011-01-06
US20110002973A1 (en) 2011-01-06
EP2184077B1 (de) 2014-05-14
US20110045054A1 (en) 2011-02-24
CA2589597C (en) 2015-04-21
DE602005018103D1 (de) 2010-01-14
CN101940801A (zh) 2011-01-12
HK1112429A1 (en) 2008-09-05
US20110229549A1 (en) 2011-09-22
ES2339798T3 (es) 2010-05-25
JP2008522735A (ja) 2008-07-03
EP2226036A1 (de) 2010-09-08
AU2005314263A1 (en) 2006-06-15
JP2008522738A (ja) 2008-07-03
CN101912637A (zh) 2010-12-15
US20130052166A1 (en) 2013-02-28
US20100318016A1 (en) 2010-12-16
AU2005314312A1 (en) 2006-06-15
CA2881343A1 (en) 2006-06-15
EP1824529B1 (de) 2010-07-21
AU2005314312B2 (en) 2010-10-07
CN101940801B (zh) 2014-04-16
US20080119946A1 (en) 2008-05-22
CN103055350A (zh) 2013-04-24
JP2012148164A (ja) 2012-08-09
IL183785A (en) 2013-03-24
EP1824526B1 (de) 2009-12-02
WO2006062962A2 (en) 2006-06-15
US20080118561A1 (en) 2008-05-22
CA2589588C (en) 2013-10-15
ATE474608T1 (de) 2010-08-15
AU2005314226A1 (en) 2006-06-15
AU2005314226B2 (en) 2011-05-19
IL183786A (en) 2011-06-30
JP2008532565A (ja) 2008-08-21
ES2490610T3 (es) 2014-09-04
IL183784A (en) 2011-03-31
CA2589597A1 (en) 2006-06-15
IL209574A (en) 2013-08-29
EP1824526A2 (de) 2007-08-29
IL183785A0 (en) 2007-09-20
JP2015042682A (ja) 2015-03-05
WO2006062962A3 (en) 2006-10-12
JP5674256B2 (ja) 2015-02-25
AU2005314263B2 (en) 2011-05-19
EP1824529A2 (de) 2007-08-29
CN103055350B (zh) 2014-12-10
JP2013039431A (ja) 2013-02-28
IL183786A0 (en) 2007-09-20
ATE450276T1 (de) 2009-12-15

Similar Documents

Publication Publication Date Title
ATE474608T1 (de) Zusammensetzungen und deren verwendung für besseren gefässzugang
SG161258A1 (en) Methods and compositions for enhancing vascular access
Lv et al. Enhanced angiogenesis and osteogenesis in critical bone defects by the controlled release of BMP-2 and VEGF: implantation of electron beam melting-fabricated porous Ti6Al4V scaffolds incorporating growth factor-doped fibrin glue
Yao et al. Fibrin-based tissue-engineered blood vessels: differential effects of biomaterial and culture parameters on mechanical strength and vascular reactivity
Mouthuy et al. Biocompatibility of implantable materials: an oxidative stress viewpoint
CN102256609B (zh) 衍生自前胃胞外基质的组织支架
US20200246508A1 (en) Natural tissue scaffolds as tissue fillers
Cholewinski et al. Tranexamic acid—an alternative to aprotinin in fibrin-based cardiovascular tissue engineering
Eweida et al. Naturally occurring extracellular matrix scaffolds for dermal regeneration: do they really need cells?
GB2434105A (en) Fibronectin-modified ECM tissue graft constructs and methods for preparation and use thereof
Morris et al. Decellularized materials derived from TSP2-KO mice promote enhanced neovascularization and integration in diabetic wounds
DE60018044D1 (de) Neue biomaterialien
CN101084026A (zh) 含有生脂间充质干细胞的聚乙二醇－双丙烯酸酯(pegda)交联的水凝胶
ATE528025T1 (de) Wachstumsfaktor-modifiziertes extrazelluläres matrixmaterial und verfahren zu seiner herstellung und verwendung
ATE402002T1 (de) Elektroverarbeitetes kollagen
Suchý et al. The effects of different cross-linking conditions on collagen-based nanocomposite scaffolds—an in vitro evaluation using mesenchymal stem cells
Deeken et al. Assessment of the biocompatibility of two novel, bionanocomposite scaffolds in a rodent model
WO2006062909A3 (en) Methods and compositions for enhancing vascular access
WO2005012492A8 (en) Human skin equivalents expressing exogenous polypeptides
ATE349232T1 (de) Biokompatibles poröses ti-ni material
DE602004025145D1 (de) Zusammengesetzte strukturen mit hyaluronsäure und derivaten davon als neue knochensubstitute und transplantate
Lei et al. Research on alginate-polyacrylamide enhanced amnion hydrogel, a potential vascular substitute material
CN105169494B (zh) 一种组织工程皮肤的制备方法
AU2007304237B2 (en) Matrix gel graft without cells
JP7467641B2 (ja) 皮膚充填剤としての架橋ｈａ－コラーゲンヒドロゲル